Latest news with #Beyond
The Star
13 hours ago
- Business
- The Star
Cancer-stricken Peter Pang works hard to recoup RM270K in living & medical bills
Hong Kong actor Peter Pang is working hard to to recoup the costs of his medical treatment. Photo: China Press Despite being diagnosed with stage three rectal cancer in July 2023, Hong Kong singer-actor Peter Pang continues to work tirelessly to recoup the costs of his medical treatment. In a recent update on Xiaohongshu (Red Note), Pang, 54, revealed that he had secured a singing gig at a nightclub in mainland China. He also shared a video from the performance, showing fans enthusiastically singing along as he belted the 1993 classic Sky – originally sung by Cantopop group Beyond. 'I'm grateful that I can still use this body to perform for everyone. I'll keep going,' he captioned his post. According to Hong Kong's Headline Daily , Pang recently admitted to struggling financially. The publication reported that after being out of work for a year to focus on his treatment, Pang has exhausted the HK$500,000 (RM270,751) he borrowed to cover both medical and living expenses. With a wife and three children to support, the former TVB star is eager to return to work to begin repaying his debts. 'No work means no income… My wife is working, but it's hard for her to shoulder everything alone. The money we borrowed is nearly gone. If this keeps up, we won't make it,' he said. Still, the Sinister Beings (2021) actor remains hopeful, adding: 'I want people to know that just because I'm sick doesn't mean I can't work. I'm still full of life. I can do this!'
Yahoo
a day ago
- Business
- Yahoo
Is Beyond, Inc. (BYON) Outperforming Other Retail-Wholesale Stocks This Year?
The Retail-Wholesale group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Beyond (BYON) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out. Beyond is one of 207 companies in the Retail-Wholesale group. The Retail-Wholesale group currently sits at #9 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups. The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Beyond is currently sporting a Zacks Rank of #2 (Buy). Over the past three months, the Zacks Consensus Estimate for BYON's full-year earnings has moved 29.9% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger. Based on the latest available data, BYON has gained about 30% so far this year. Meanwhile, stocks in the Retail-Wholesale group have gained about 1.8% on average. As we can see, Beyond is performing better than its sector in the calendar year. Another stock in the Retail-Wholesale sector, CHOW TAI FOOK (CJEWY), has outperformed the sector so far this year. The stock's year-to-date return is 60.8%. Over the past three months, CHOW TAI FOOK's consensus EPS estimate for the current year has increased 20.4%. The stock currently has a Zacks Rank #1 (Strong Buy). Looking more specifically, Beyond belongs to the Internet - Commerce industry, a group that includes 37 individual stocks and currently sits at #65 in the Zacks Industry Rank. This group has gained an average of 0.8% so far this year, so BYON is performing better in this area. In contrast, CHOW TAI FOOK falls under the Retail - Jewelry industry. Currently, this industry has 6 stocks and is ranked #66. Since the beginning of the year, the industry has moved -18.1%. Beyond and CHOW TAI FOOK could continue their solid performance, so investors interested in Retail-Wholesale stocks should continue to pay close attention to these stocks. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Beyond, Inc. (BYON) : Free Stock Analysis Report CHOW TAI FOOK (CJEWY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 days ago
- Business
- Yahoo
5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost
President Trump's recent decision to delay the implementation of tariffs on goods from the European Union till July 9 has been well received by markets. Trump has delayed his decision to impose 50% tariffs on EU imports from June 1 to allow talks between Washington and the EU with the objective of arriving at a deal. Another encouraging development was the surge in May consumer confidence. The primary driver of the increase was the progress in U.S.-China trade negotiations, with President Trump deciding earlier in the month to halt severe tariffs. In this reassuring scenario, keeping an eye on broker-favorite stocks like Beyond BYON, BrightSpring Health Services BTSG, Air Canada ACDVF, Emergent BioSolutions EBS and Adient Plc ADNT appears prudent. We have designed a screen to shortlist stocks based on improving broker recommendations and upward revisions in earnings estimates over the past four weeks. Also, since the price/sales ratio is a strong complementary valuation metric in the presence of broker information, it has been included. The price/sales ratio takes care of the company's top line, making the strategy a well-rounded one. # (Up- Down Rating)/ Total (4 weeks) =Top #75 (This gives the list of top 75 companies that have witnessed net upgrades over the last 4 weeks). % change in Q (1) est. (4 weeks) = Top #10 (This gives the top 10 stocks that have witnessed earnings estimate revisions over the past 4 weeks for the upcoming quarter). Price-to-Sales = Bot%10 (The lower the ratio, the better. Companies meeting this criterion are in the bottom 10% of our universe of over 7,700 stocks with respect to this ratio). Price greater than 5 (as a stock trading below $5 will not likely create significant interest for most of the investors). Average Daily Volume greater than 100,000 shares over the last 20 trading days (Volume has to be significant to ensure that these are easily traded). Market value ($ mil) = Top #3000 (This gives us stocks that are the top 3000 in terms of market capitalization). Com/ADR/Canadian= Com (This eliminates the ADR and Canadian stocks). Here are five of the 10 stocks that made it through the screen: Beyond, based in Murray, UT, is an e-commerce-focused retailer with an affinity model that owns or has ownership interests in various retail brands. The company offers a comprehensive array of products and services that enable its customers to enhance their daily lives. BYON beat the Zacks Consensus Estimate for earnings in two of the trailing four quarters, missing the mark in the other two. The average beat is 3.7%. Beyond currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here BrightSpring provides complementary and integrated home- and community-based pharmacy and health solutions for complex populations in need of specialized and/or chronic care. Through its service lines, including pharmacy, home health care and primary care, rehabilitation, and behavioral health, the company provides comprehensive care and clinical solutions in all 50 states to over 400,000 customers, clients and patients daily. BrightSpring's 2025 earnings growth rate is pegged at 82.1%. The Zacks Consensus Estimate for BTSG's 2025 revenues indicates a rise of 9.1% from 2024's actuals. The stock carries a Zacks Rank #2 currently. Air Canada has been benefiting from the impressive scenario in air travel demand. Low fuel costs represent another tailwind. The Zacks Consensus Estimate for 2026 sales and earnings has increased 5.6% and 25.7%, respectively, on a year-over-year basis. The Zacks Consensus Estimate for current-year earnings has increased 2.1% over the past seven days. ACDVF currently carries a Zacks Rank #3 (Hold). Emergent BioSolutions derives a substantial portion of its revenues from the sales of its anthrax and smallpox vaccines to the U.S. government, which the latter procures for the strategic national stockpile. These procurements are done under fixed-term contracts. Any loss of existing contracts or failure to get new or follow-on contracts may significantly hurt the company's prospects. EBS beat the Zacks Consensus Estimate for earnings in three of the trailing four quarters, missing the mark in the other quarter. The average beat was 49.9%. Emergent BioSolutions currently carries a Zacks Rank of 3. Dublin, Ireland-based Adient is one of the world's largest automotive seating suppliers. Adient has been gaining customers with its broad range of products. A diverse customer base and international presence have helped the company create a strong market position. ADNT beat the Zacks Consensus Estimate for earnings in three of the trailing four quarters, missing the mark in the other quarter. The average beat is 18.3%. Adient currently carries a Zacks Rank of 3. You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial to the Research Wizard today. Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. Disclosure: Performance information for Zacks' portfolios and strategies are available at: Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Emergent Biosolutions Inc. (EBS) : Free Stock Analysis Report Adient (ADNT) : Free Stock Analysis Report Air Canada (ACDVF) : Free Stock Analysis Report Beyond, Inc. (BYON) : Free Stock Analysis Report BrightSpring Health Services, Inc. (BTSG) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
19-05-2025
- Business
- Yahoo
Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions
Chicago, IL – May 19, 2025 – Stocks in this week's article are BrightSpring Health Services BTSG, Beyond BYON, Air Canada ACDVF, HF Sinclair DINO and Emergent BioSolutions EBS. The broader U.S. equity markets have been performing well lately, driven by positive updates on the trade front and a cooling inflationary trend. The Federal Reserve's decision to keep interest rates unchanged in its latest policy meeting and the better-than-expected first-quarter 2025 earnings season also contributed to the market's newfound enthusiasm. With more tariff-related good news expected, markets are likely to gain further in the coming days. To take advantage of this rosy evolving situation, investors would do well to monitor broker-favored stocks like BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions. We have designed a screen to shortlist stocks based on improving broker recommendations and upward revisions in earnings estimates over the past four weeks. Also, since the price/sales ratio is a strong complementary valuation metric in the presence of broker information, it has been included. The price/sales ratio takes care of the company's top line, making the strategy a well-rounded one. Here are five of the 10 stocks that made it through the screen: BrightSpring: The company provides complementary and integrated home- and community-based pharmacy and health solutions for complex populations in need of specialized and/or chronic care. Through BTSG's service lines, including pharmacy, home health care and primary care, and rehabilitation and behavioral health, the company provides comprehensive care and clinical solutions in all 50 states to over 400,000 customers, clients and patients daily. BrightSpring's 2025 earnings growth rate is pegged at 82.1%. The Zacks Consensus Estimate for BTSG's 2025 revenues indicates a rise of 9.1% over 2024. The stock carries a Zacks Rank #2 (Buy) currently. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here Beyond, based in Murray, UT, is an e-commerce-focused retailer with an affinity model that owns or has ownership interests in various retail brands. The company offers a comprehensive array of products and services that enable its customers to enhance their daily lives. BYON beat the Zacks Consensus Estimate for earnings in two of the trailing four quarters, missing the mark in the other two. The average beat is 3.7%. Beyond currently carries a Zacks Rank of 3 (Hold). Air Canada has been benefiting from the impressive scenario in air travel demand. Low fuel costs represent another tailwind. The Zacks Consensus Estimate for 2026 sales and earnings has increased 5.7% and 27.3%, respectively, on a year-over-year basis. The Zacks Consensus Estimate for current-year earnings has increased 2.1% over the past seven days. ACDVF currently carries a Zacks Rank #3. HF Sinclair is a producer and marketer of gasoline, diesel fuel, and other specialty products. HF Sinclair pays out a quarterly dividend of 50 cents ($2 annualized) per share, which gives it a 5.37% yield at the current stock price. This #3 Ranked company's five-year dividend growth rate is 9.17%. DINO is currently valued at $7.01 billion. The Zacks Consensus Estimate for HF Sinclair's 2025 earnings has been revised 9.9% upward over the past seven days. The downstream operator has a trailing four-quarter earnings surprise of 26.6%, on average. Emergent BioSolutions derives a substantial portion of its revenues from the sales of its anthrax and smallpox vaccines to the USG, which the latter procures for the strategic national stockpile. These procurements are done under fixed-term contracts. Any loss of existing contracts or failure to get new or follow-on contracts may significantly hurt the company's prospects. EBS beat the Zacks Consensus Estimate for earnings in three of the trailing four quarters, missing the mark in the other quarter. The average beat is 49.9%. Emergent BioSolutions currently carries a Zacks Rank of 3. You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial to the Research Wizard today. For the rest of this Screen of the Week article please visit at: Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. About Screen of the Week created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Strong Stocks that Should Be in the News Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>. Follow us on Twitter: Join us on Facebook: Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Contact: Jim Giaquinto Company: Phone: 312-265-9268 Email: pr@ Visit: provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit information about the performance numbers displayed in this press release. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Emergent Biosolutions Inc. (EBS) : Free Stock Analysis Report Air Canada (ACDVF) : Free Stock Analysis Report HF Sinclair Corporation (DINO) : Free Stock Analysis Report Beyond, Inc. (BYON) : Free Stock Analysis Report BrightSpring Health Services, Inc. (BTSG) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Economic Times
19-05-2025
- Business
- Economic Times
Foresight, Female Founders, and the Future - Vera Futorjanski on Building Big in Dubai
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel That's not a pitch—it's a reflection. Vera Futorjanski, founder of Veritas Ventures and a driving force behind several of Dubai's innovation milestones, joined the Live, Work & Play in Dubai podcast to share how the city's culture of foresight, inclusion, and speed has shaped her journey—and why it's a launchpad for founders arrived in Dubai a decade ago as an entrepreneur-in-residence for Rocket Internet. She stayed for four months—then never left. 'I wouldn't have had the same opportunities anywhere else in the world,' she said. 'I was here at the right time when Dubai decided we are going to diversify from oil and become the most innovative city on the planet.'That commitment wasn't just policy—it was participation. Vera became part of the founding team of Dubai Future Accelerators, a government-led platform that embedded startups inside public entities like Roads & Transport Authority (RTA), Dubai Electricity & Water Authority (DEWA), and the Health Authority.'We sat together, imagined a future 10, 20, 30 years ahead, and then scouted the world to find companies working on those topics—be it Hyperloop or blockchain. Then we brought them to Dubai and paired them with government teams. That's how real innovation happened.'For Indian businesses and entrepreneurs, this model presents a unique opportunity—working not around the system, but within it. Whether in smart mobility, digital identity, or urban tech, Dubai offers structured collaboration at her firm Veritas Ventures, Vera now helps governments, corporates, and scaleups define future scenarios and work backwards to get there.'It's about leading from the future. We ask: What do we want our preferred future to look like? And then we reverse-engineer it,' she explained. 'In a world of uncertainty, the ability to anticipate trends and prepare for them is not a luxury—it's a leadership skill.'This resonates strongly with India's tech ecosystem, which is also navigating rapid transitions in AI, climate, and urban growth. The difference? Dubai's public-private alignment accelerates initiative Beyond brings together women from across cultures and industries. 'In Dubai, I'm surrounded by empowered Arab women. But in Europe, many have never met one. I wanted to change that.'She curates gatherings with '10 women from 10 different countries,' fostering connection over transaction. 'You go deeper. That's why I love this region—it's about relationship-building.'She notes that platforms like DIFC's Ignite, Female Angels, and E7 are creating space for more female entrepreneurs and investors, something Indian founders can increasingly tap into.'Globally, only 2% of VC funding goes to women. Here, it's even less,' Vera noted. 'Men are asked visionary questions. Women are asked about the status quo.'Her advice? 'Say your vision, even if you're not asked. Politicians do it all the time—founders should too. We need more women on the other side of the table—female investors who relate to the founders in front of them. That's how real change will happen.'Dubai's startup ecosystem isn't just tech-friendly—it's accessible. 'In Europe, you send a fax. In Dubai, Emirates Post replies on Instagram,' Vera laughed. 'That digital efficiency is a game-changer.'Her advice to Indian entrepreneurs considering Dubai: 'Join communities. Don't do it alone. This city thrives on creativity and relationships.''I started as a professional dancer, then moved into politics, then tech. I've pivoted three times—and Dubai made all of that possible,' Vera a city where speed meets scale and vision meets execution; reinvention isn't an exception—it's the norm. 'That's the beauty of Dubai. It doesn't wait for the future. It builds it.'Click this lin link k for more on Business in Dubai.
